Better long-term outcomes with early intensive MS therapy: study
Do current escalation approaches miss a therapeutic opportunity?
Staff Writer
21st February 2019
Multiple sclerosis (MS) patients who receive high-efficacy therapy early fare better long-term than those on an escalation-based approach to treatment, according to new research.